Anti-CD22 [hL22 (Epratuzumab)]

Description:

Recombinant monoclonal antibody to CD22. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma hL22 (Epratuzumab).

Clone Name:
hL22 (Epratuzumab)
Published Application(s):
Blocking, IP, FC
Published Species Reactivity:
Human, Rhesus Monkey, Cynomolgus Monkey
7
Products based on this clone:
  • {{heading}}
Please Select
  • Ab00728-10.0 Anti-CD22 [hL22 (Epratuzumab)]
  • Human, Rhesus Monkey, Cynomolgus Monkey
  • Human IgG1
  • Purified
  • In Stock
  • Ab00728-23.0 Anti-CD22 [hL22 (Epratuzumab)]
  • Human, Rhesus Monkey, Cynomolgus Monkey
  • Rabbit IgG
  • Purified
  • In Stock
  • Ab00728-35.0 Anti-CD22 [hL22 (Epratuzumab)]
  • Human, Rhesus Monkey, Cynomolgus Monkey
  • Cynomolgus monkey IgG1
  • Purified
  • Enquire for Availability
  • Ab00728-36.0 Anti-CD22 [hL22 (Epratuzumab)]
  • Human, Rhesus Monkey, Cynomolgus Monkey
  • Cynomolgus monkey IgG4
  • Purified
  • Enquire for Availability
  • Ab00728-26.0 Anti-CD22 [hL22 (Epratuzumab)]
  • Human, Rhesus Monkey, Cynomolgus Monkey
  • Rhesus macaque IgG1
  • Purified
  • Enquire for Availability
  • Ab00728-37.0 Anti-CD22 [hL22 (Epratuzumab)]
  • Human, Rhesus Monkey, Cynomolgus Monkey
  • Rhesus macaque IgG4
  • Purified
  • Enquire for Availability
Loading...